Announcement BIO Europe 2024 : A dual approach to treat autism and brain tumors
Prof. Yehezkel Ben-Ari will participate in BIO Europe meeting in Stockholm early November to develop partnerships with Pharma’s & investors to treat autism and brain tumors.The Co-transporter NKCC1 that regulates GABAergic inhibition and cell volume is overactive in many brain disorders including autism, fragile X and Rett syndrome, brain trauma, epilepsies, brain traumas cerebro-vascular infarcts, … Read more
